KAMRAB 150UI / ml solution for injection medication leaflet

J06BB05 human anti-rabies immunoglobulin • Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins

Human rabies immunoglobulin is a plasma-derived product used to prevent rabies in individuals exposed to the rabies virus, usually through bites from infected animals. It provides passive immunity by supplying specific antibodies against the rabies virus.

The medication is administered via intramuscular injection, as directed by a doctor, and is used in combination with the rabies vaccine.

Side effects may include pain at the injection site, fever, allergic reactions, or, in rare cases, anaphylactic reactions.

Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about KAMRAB 150UI / ml

Substance: human anti-rabies immunoglobulin

Date of last drug list: 01-05-2026

Commercial code: W71777001

Concentration: 150UI / ml

Pharmaceutical form: solution for injection

Quantity: 1

Product type: generic

Price: 1688.59 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: KAMADA LTD. - ISRAEL

Holder: CN UNIFARM S.A. - ROMANIA

Number: 1208/2026/01